End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.26 CNY | +2.40% | +2.40% | -25.13% |
Apr. 18 | Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | YiBai Pharma to Repurchase Up to 40 Million Yuan Shares | MT |
Sales 2022 | 2.74B 379M | Sales 2023 | 2.82B 391M | Capitalization | 4.51B 625M |
---|---|---|---|---|---|
Net income 2022 | -426M -59.04M | Net income 2023 | 103M 14.27M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 495M 68.55M | Net Debt 2023 | 301M 41.68M | EV / Sales 2023 | 1.7 x |
P/E ratio 2022 |
-10.3
x | P/E ratio 2023 |
43.4
x | Employees | 5,509 |
Yield 2022 * |
-
| Yield 2023 |
1.16% | Free-Float | 68.33% |
1 day | +2.40% | ||
1 week | +2.40% | ||
Current month | +2.40% | ||
1 month | -13.24% | ||
3 months | +2.65% | ||
6 months | -26.80% | ||
Current year | -25.13% |
Managers | Title | Age | Since |
---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Xian Hong Jiang
DFI | Director of Finance/CFO | 39 | 20-03-22 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Ling Dou
FOU | Founder | 64 | 95-05-31 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 4.26 | +2.40% | 11,474,800 |
24-04-30 | 4.16 | 0.00% | 11,189,600 |
End-of-day quote Shanghai S.E., May 05, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-25.13% | 468M | |
+31.52% | 690B | |
+24.15% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.79% | 235B | |
+4.11% | 199B | |
-10.35% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 600594 Stock